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012.02.0Abstract Aim: We aimed to evaluate the prognostic value of commissural morphology on imme-
diate and short term outcome after Percutaneous balloon mitral valvuloplasty (PBMV).
Methods: The study included 30 patients with symptomatic mitral stenosis (MS) scheduled for
PBMV with these exclusion criteria: left atrial thrombi, High echocardiography score, Moderate
to severe mitral regurgitation (MR), Atrial ﬁbrillation (AF) or Calciﬁcation. After PBMV, they
were randomized into 2 groups: Group I: 12 patients with only opened one commissure and group
II: 18 patients with bilateral opened commissures.
Results: Following PBMV, the mean mitral valve area (MVA) increased from 0.94 ± 0.19 to
1.86 ± 0.27 cm2 in group I & from 0.91 ± 0.18 to 2.29 ± 0.33 cm2 in group II (p= 0.001). The
mean transmitral gradient (MG) decreased from 21.83 ± 4.1 to 8.08 ± 2.9 mmHg in group I
and from 18.28 ± 5 to 5.2 ± 1.76 mmHg in group II (p= 0.003). The MVA was
1.85 ± 0.23 cm2 in group I and 2.25 ± 0.31 cm2 in group II (p= 0.001) and MG was
8.09 ± 2.90 mmHg in group I and 5.47 ± 1.79 mmHg in group II (p= 0.001). Three month fol-
low-up: there was no patient developed AF, embolization or severe MR. Also, there was no mor-
tality, redo, or surgery.
Conclusion: We concluded that degree of commissural opening and MVA are closely related. The
complete bilateral commissural opening is associated with better sustained MVA and functional
status. Thus, evaluation of the degree of commissural opening can be considered as a complemen-
tary measure of the procedural success in PBMV.
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131. Introduction
Rheumatic heart disease (RHD) is an important contributor to
cardiovascular disease in Egypt and many developing coun-
tries. About 25 percent of all patients with rheumatic heart dis-
ease have isolated mitral stenosis.1 Rheumatic fever results in
characteristic changes of the mitral valve with the diagnostic
features being thickening at the leaﬂet edges, fusion of theg by Elsevier B.V. All rights reserved.
234 M.A. Sadaka et al.commissures, and chordal shortening and fusion. Subsequent
scarring leads to the characteristic valve deformity with oblit-
eration of the normal leaﬂet architecture by ﬁbrosis, neovascu-
larization and increased collagen and tissue cellularity.
Superimposed calciﬁcation results in further dysfunction.2
Obstruction at the mitral valve level has important hemody-
namic consequences, which account for many of the adverse
clinical outcomes associated with this disease. Elevated left at-
rial pressure results in pulmonary artery hypertension with sec-
ondary effects on the pulmonary vasculature and right heart.
In addition, left atrial enlargement and development of atrial
ﬁbrillation are associated with an increased risk of thrombus
formation and systemic embolism.3
Commissural fusion is recognized as the principal pathol-
ogy underlying mitral stenosis, and commissural splitting
underlies successful interventional treatment. Although the
technique of surgical commissurotomy was ﬁrst described as
early as 1948,4 percutaneous commissurotomy became a feasi-
ble option with the advent of balloon mitral valvuloplasty in
1984.5 PBMV is now the treatment of choice for many patients
with symptomatic mitral stenosis. Numerous large series have
reported excellent short, medium, and long-term outcome5–8
with a low incidence of serious complications.9 Furthermore,
randomized trials comparing balloon valvuloplasty with the
surgical alternatives of open or closed commissurotomy have
demonstrated equivalent outcome.10,11 However, patients trea-
ted using the percutaneous approach enjoy the advantages of
reduced procedural morbidity and mortality and a short hos-
pital stay. According to the last American College of Cardiol-
ogy (ACC) and American Heart Association (AHA) guidelines
focused update published in 2008, PBMV is considered as class
I level of evidence A for the treatment of symptomatic patients
(NYHA functional class II, III, or IV), with moderate or se-
vere MS and valve morphology favorable for PBMV in the ab-
sence of left atrial thrombus or moderate to severe MR.12
The outcomes of PBMV in different patients with MS are
variable, in this study we aim to evaluate the prognostic value
of commissural morphology on immediate and short term out-
comes after the intervention.
2. Methods
2.1. Study population
The study population consisted of 30 patients with symptom-
atic mitral stenosis scheduled for percutaneous balloon mitral
valvuloplasty admitted to the Department of cardiology, Alex-
andria Main University Hospital. Major criteria for exclusion
were the presence of left atrial thrombi on transesophageal
echocardiography (TEE), high Wilkin’s echocardiographic
score > 12, moderate to severe mitral regurgitation, calciﬁca-
tion of commissures and previous mitral valve balloon valvu-
loplasty or surgery.
All patients were clinically reviewed to emphasize the history
of rheumatic fever and the NYHA functional class. Standard 12
lead ECG was done to detect arrhythmia. Transthoracic echo-
cardiography (TTE) using a commercial HP Sonos 4500 echo-
cardiography machine was performed the day before and 24
to 48 h after the procedure then three months after PBMV for
evaluation of the following: MVA as measured by planimetry;
from 2D short axis images and Doppler pressure half time.Mitral valve anatomy will be assessed according toWilkin’s cri-
teria.12 Mean transmitral diastolic gradient was assessed by
continuous-wave Doppler. Mitral regurgitation will be semi-
quantitatively graded from 0 to 4 by color ﬂow mapping.
The degree of commissural pathology will be evaluated (in a
parasternal short-axis view) as regards; calciﬁcation, number
(unilateral or bilateral) and degree (partial or complete) of
commissural closure. After PBMV (within ﬁrst 48 h & then
after 3 months) the commissures were assessed for the number
and degree of commissural opening. Preprocedure TEE (with-
in 24 h before procedure) was done to exclude left atrial throm-
bi and also to reassess Wilkin’s score and interatrial septal wall
thickness. At three months follow up: all patients were clini-
cally reviewed for NYHA class, new onset atrial ﬁbrillation,
rehospitalization and need for redo or surgery.
2.2. Mitral balloon valvuloplasty using multitrack system
technique: (Fig. 1)
Dilation of the valvular oriﬁce is performed on fasting patients
under local anesthesia. Trans-septal puncture is the ﬁrst and
most crucial step of the procedure. This is done via the right
femoral vein, monitoring arterial pressure by placing a pigtail
catheter at the aortic root through the right femoral artery,
usually through a 6 French sheath (Fig. 1, a). After accessing
the femoral vein, 7 French Mullins dilator is passed over an ex-
change length wire of 0.025 or 0.032 inches diameter into the
superior caval vein. The Brockenbrough needle is then passed
to its tip into the Mullins dilator. With the index of the Broc-
kenbrough needle pointing posteromedially, at 4 o’ clock or 5
o’ clock at the groin, the entire assembly is pulled down from
the superior caval vein in anteroposterior view until it engages
the atrial septum in the region of the fossa ovalis. Following
this, the assembly of the Mullins dilator, with the needle just
proximal to its tip, is manipulated in the lateral view, probing
for the fossa. Once the assembly is ﬁxed in the fossa, the ﬂoor
is punctured by ﬁrm pressure on the dilator. As soon as the
whole assembly enters the left atrium, atrial entry is conﬁrmed
by recording the waveform of the left atrial pressure, by oxim-
etry, and by injection of contrast into the left atrium. After
conﬁrming entry to the left atrium, 100 units of heparin per
kilogram of body weight are given in order to minimize the
risk of thrombosis, and the gradient across the mitral valve
is recorded by simultaneous recording of left atrial and left
ventricular pressures. A balloon tipped Swan Ganz catheter
is secured into the left ventricle through the Mullins sheath.
A long stainless steel guide wire with a coiled ﬂoppy tip,
180 cm long, and of 0.025 inches in diameter, is then inserted
into the left ventricle (Fig. 1, b). Following this, the site of sep-
tal puncture is dilated by passing a 14 French polyethylene
dilator over the guidewire. Then two separate balloon cathe-
ters are positioned on a single guidewire. The ﬁrst catheter,
with only a distal guidewire lumen, is introduced into the vein
and then advanced into the mitral oriﬁce, then inﬂated alone
(Fig. 1, c). Subsequently, a rapid exchange balloon catheter
running on the same guidewire is inserted, and lined up with
the ﬁrst catheter so the two are positioned side-by-side,
(Fig. 1, d). Both balloons are then inﬂated simultaneously.
The sum of the diameters of the two balloons chosen is around
90 to 100% of the measured value for the mitral valve annulus,
(Fig. 1, e).
Figure 1 Mitral balloon valvuloplasty using multitrack system.
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following
 Mitral valve area greater than 1 cm2/m2 body surface
area with split ends of the zone of apposition between
the valvular leaﬂets.
 It is important to estimate the extent of splitting of the
zone of apposition by using cross-sectional echocardi-
ography in the short-axis view.
 Ends of the zone of apposition are sufﬁciently split to a
point near the annulus; further dilation will cause signif-
icant mitral regurgitation. Similarly, if only one end is
adequately split, further dilation requires extra care
because of risk of excessive avulsion of that area to
the mitral annulus, resulting in severe mitral
regurgitation. Mean gradient across mitral valve of less than 5 mmHg.
 Development of severe mitral regurgitation or an
increase in severity of mitral regurgitation by one grade
in patients with pre-existing mild to moderate mitral
regurgitation.
2.4. Statistical analysis
All clinical, biological, echocardiographic and procedural data
of all the patients were regularly recorded on standard forms
and stored. Statistical analyses were performed with Microsoft
Excel and SPSS software. Data were summarized using means
and standard deviation (SD) for continuous variables, and fre-
quency for categorical variables. Univariate analysis was per-
formed either by student’s t-test or Chi-square test, as
appropriate. All P-values were signiﬁcant if 6 0.05.
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The studied patients were divided prospectively into 2 groups:
Group I: 12 patients with only 1 mitral commissure opened
after PBMV.
Group II: 18 patients with both mitral commissures opened
after PBMV.
3.1. The demographic characters of the patients
Group I included 12 patients, 11females (91.67%) and 1male
(8.33%), their mean age was 29 ± 6.8 years ranging between
(19–40) years. On the other hand there were 2 males (11.1%)
and 16 females (88.8%) in group II their mean age was
20.9 ± 3.2 years ranging between (17–29) years. There was no
statistical signiﬁcant differences between the 2 studied groups
regarding sex but there was statistical signiﬁcant difference be-
tween the 2 studied groups as regarding age. (P= 0.0001*). As
seen in Table 1.
3.2. Clinical presentation
All patients were complaining of dyspnea ranging from
NYHA functional class (I–IV) with no statistical signiﬁcant
difference between the 2 studied groups with most of them
were in NYHA functional class III (66.6%). No one com-
plained of orthopnea or PND. There was no history of previ-
ous embolization or previous commissurotomy.
3.2.1. Echocardiography
Baseline characteristics of group 1 and group 2 are summa-
rized in Tables 2 and 4 respectively.
MVA ranged between (0.6–1.3) cm2 with a mean of
0.94 + 0.2 cm2 in group I and between (0.7–1.4 cm2) with a
mean of 0.9 + 0.18 cm2 in group II, with no statistically signif-
icant difference between the two groups as seen in Table 6.
Mitral valve score according to Wilkin’s criteria ranged be-
tween (6–10) with a mean of 8.2 + 1.2 in group I and ranged be-
tween (6–12) with a mean of 8.1 + 1.4 in group II with most of
the patients having ﬂexible valve and moderate subvalvular dis-
ease. In group I the mean diastolic gradient ranged between
(16–28) mmHg with a mean of 21.83 ± 4.13 mmHg, and ranged
between (11–26) mmHg in group II with a mean ofTable 1 Comparison between studied groups regarding age &
sex.
Group I Group II
(n= 12) (n= 18)
Age
Range 19–40 17.0–29.0
Mean 29 20.9
SD 6.86 3.24
P 0.001*
Sex
Male 1 (8.33%) 2 (11.11%)
Female 11 (91.67%) 16 (88.89%)
X2 0.06
P 0.80
* p is signiﬁcant < 0.05.18.28 ± 5.00 mmHg, the mean diastolic gradient of MV was
higher in group 1 than in group 2 with statistically signiﬁcant dif-
ference (p= 0.02) as seen in Table 7. As regards MR, in group I
there were 9 patients who had noMRand 3 patients hadmild de-
gree of MR on the other hand in group II there were 11 patients
who had no MR, 3 patients had trivial degree of MR and 4 pa-
tients hadmild degree ofMR,with no statistical signiﬁcant differ-
ence between the two studied groups. As seen in Table 8.
PAP ranged between (25–55) mmHg with mean of
37 ± 8.8 mmHg in group I & between (30–90) mmHg with a
mean of 52.4 ± 21 mmHg in group II. 11 patients had mild
pulmonary hypertension (PHTN) and only one patient had
moderate PHTN in group I, in comparison with group II, there
were 9 patients who had mild PHTN,7 patients had moderate
PHTN and & 2 patients had severe PHTN with no statistical
signiﬁcant difference between the two studied groups. In all
our patients no one had LAA thrombi. LA diameter ranged be-
tween (43–50) mm & (42–66) mm in groups I and II with a
mean of 46.5 ± 2.4 mm &49.4 ± 7.5 mm respectively with no
statistical signiﬁcant difference between the two studied groups.
3.2.2. Months follow up
The impact of commissural splitting was reassessed after
3 months in all patients. Follow-up was complete in all pa-
tients. During follow up no recorded cases of death, hospital
admission, redo, or surgery or infective endocarditis & most
of them were in NYHA functional class (I–II).
The MVA ranged between (1.6–2.1) with mean 1.8 cm2 in
group I and ranged between (1.8–3.1) with mean 2.2 cm2 in
group II with highly statistical signiﬁcant difference between
the two studied groups (p= 0.001) and there was no difference
in MVA between immediate follow up and three months fol-
low up. The mean transmitral gradient ranged between (3–
12) with mean 8.09 mmHg in group I and ranged between
(3–9) with mean 5.47 mmHg in group II with highly statistical
signiﬁcant difference between the 2 studied groups (p= 0.001)
and there was no difference in transmitral gradient between
immediate follow up and three months follow up.
As regards the degree of MR, opening of 2 commissures in
group II had more newly developed MR but with no statistical
signiﬁcant difference between the two groups and there was no
difference in the degree of mitral regurgitation between imme-
diate follow up and three months follow up.
The immediate and three months follow up of group 1 and
group 2 are summarized in Tables 3 and 5 respectively.
A case example of female patient of 21 years old; belonging
to group 2 is summarized in (Fig. 2).
4. Discussion
Pioneering clinical and pathology studies have shown that
commissural opening is the main mechanism by which MVA
increases after balloon valvuloplasty (percutaneous commis-
surotomy).13 Commissural calciﬁcation, an important predic-
tor of unsuccessful commissurotomy and failure of
commissural opening is associated with a poor midterm event
free survival and a high incidence of mitral valve replace-
ment.13,14 However, the relationship between the degree of
commissural opening and post-procedural MVA has not been
extensively evaluated.
Table 2 Echocardiography data before PBMV.
No Echocardiography data before PBMV
MVA Eecho score MG MR IR LA
2D Modify Score
1 1 2 4 2 2 10 28 Mild 1 closed + 1 partial Mild 47 50
2 0.9 2 2 4 0 8 22 No 1 closed + 1 partial Mild 43 50
3 0.6 3 3 2 0 8 16 No 2 closed Mild 42 50
4 0.7 2 3 2 0 7 22 Mild 2 closed No 55 45
5 1 3 3 3 0 9 23 No 2 closed Mild 30 43
6 0.9 2 3 3 1 9 26 No 1 closed + 1 partial Moderate 28 45
7 0.9 2 2 2 0 6 21 No 2 closed Mild 36 45
8 1.2 3 1 3 1 8 28 Mild 2 closed No 38 47
9 1.3 3 3 4 0 10 16 No 2 closed No 34 46
10 0.8 2 1 3 1 7 18 No 2 closed No 25 45
11 0.9 3 2 3 0 8 23 No 2 closed Mild 38 48
12 1.1 2 2 4 1 9 19 No 2 closed Mild 28 44
Table 3 Clinical and Echo data of of group I after PBMV.
Immediate follow up 3 months follow up
AF Surgery MG MVA MR NFHA AF Redo Surgery 2D MR MG
2D
1 No No 5 2.3 Mild I No No No No 2.1 Mild 8
2 No No 12 1.6 Mild II No No No No 1.6 Mild 12
3 No No 10 1.7 Trivial I No No No No 1.7 Trivial 10
4 No No 12 1.6 Mild II No No No No 1.6 Mild 12
5 No No 8 1.8 Mild I No No No No 1.7 Mild 8
6 No No 7 1.8 Mild I No No No No 1.8 Mild 7
7 No No 9 1.7 Trivial I No No No No 1.6 Trivial 9
8 No No 11 1.6 Mild II No No No No 1.6 Mild 12
9 No No 6 1.9 Mild I No No No No 1.9 Mild 6
10 No No 4 2 None I No No No No 2 None 5
11 No No 7 2.3 None I No No No No 2.2 None 7
12 No No 3 2.1 none I No No No No 2 None 3
Table 4 Echocardiography data before PBMV.
No Echocardiography data before PBMV
MVA Eecho score MG MR Commissars TR Mean PAP LA
2D Modify Score
1 0.5 2.0 3.0 4.0 2.0 12 14 56 Bilateral Mild 30 56
2 1.2 3 2 2 0 7 12 45 Both closed Mild 55 45
3 0.5 3 2 2 1 8 26 55 1closed + 1 partial Trivial 45 55
4 0.9 2 2 3 0 7 15 66 2closed Moderate 70 66
5 1.1 3 4 3 0 10 21 43 2closed Mild 40 43
6 0.5 2 2 3 1 5 24 43 2closed Mild 90 43
7 0.9 2 2 4 1 9 11 52 1closed + 1 partial No 30 52
8 1.4 2 2 2 0 6 21 42 2closed Trivial 30 42
9 0.9 2 2 3 1 5 14 50 2closed Mild 60 50
10 0.7 2 2 3 0 7 15 43 1closed + 1 partial Moderate 70 45
11 1 2 3 2 0 7 16 45 2closed Mild 30 45
12 0.8 3 4 3 0 10 26 66 2closed Moderate 70 66
13 0.7 3 2 3 1 9 19 43 2closed Mild 40 43
14 0.5 2 2 4 1 9 21 43 2closed Mild 90 43
15 0.9 3 2 2 0 7 24 52 1closed + 1 partial No 30 52
16 1 2 2 3 1 8 11 42 2closed Trivial 30 42
17 0.9 2 2 3 0 7 21 50 2closed Mild 60 50
18 0.5 2 3 2 0 7 14 45 1closed + 1 partial Moderate 70 45
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Table 5 Clinical and Echo data of of group II after PBMV.
No. Immediate follow up 3 months follow up
AF Surgery MG MVA MR NFHA AF Redo Surgery 2D MR MG
2D
1 No No 3 2.2 Mild I No No No No 2.1 Mild 3
2 No No 5 2.5 Mild I No No No No 2.5 Mild 5
3 No No 8 3.1 Mild I No No No No 3.1 Mild 9
4 No No 3 2.5 Trivial I No No No No 2.5 Trivial 3
5 No No 7 2.8 Mild II No No No No 2.6 Mild 8
6 No No 6 2.1 Mild II No No No No 1.8 Mild 6
7 No No 3 2.1 Mild I No No No No 2 Mild 3
8 No No 6 2 Mild I No No No No 2 Mild 6
9 No No 4 2.1 Mild I No No No No 2.1 Mild 4
10 No No 6 2.1 Mild I No No No No 2.1 Mild 6
11 No No 5 2.1 Mild I No No No No 2.1 Mild 5
12 No No 8 2.5 Trivial I No No No No 2.5 Trivial 8
13 No No 3 2.8 Mild II No No No No 2.1 Mild 3
14 No No 7 2.1 Mild I No No No No 2.6 Mild 7
15 No No 6 2.1 Mild I No No No No 2.1 Mild 7
16 No No 3 2 Mild I No No No No 2 Mild 3
17 No No 6 2.1 Mild I No No No No 2.1 Mild 6
18 No No 4 2.1 Mild I No No No No 2.1 Mild 4
Table 6 MVA in different interval times of follow up.
Group I Group II P
Before
Range 0.6–1.3 0.7–1.4 0.335
Mean 0.942 0.91
SD 0.198 0.18
Immediate follow up
Range 1.6–2.3 2.0–3.1 0.001*
Mean 1.867 2.29
SD 0.257 0.33
3 months after
Range 1.6–2.1 1.8–3.1 0.001*
Mean 1.850 2.25
SD 0.235 0.31
* p is signiﬁcant < 0.05.
Table 7 Mean diastolic gradient of MV during follow up.
Group I Group II P
Before
Range 16–28 11.0–26.0 0.022*
Mean 21.833 18.28
SD 4.130 5.0
Immediate follow up
Range 3–12 3.0–8.0 0.003*
Mean 8.083 5.17
SD 2.906 1.76
3 months after
Range 3–12 3.0–9.0 0.003*
Mean 8.093 5.47
SD 2.906 1.76
* p is signiﬁcant < 0.05.
Table 8 MR in different interval times of follow up.
MR Group I Group II X2
No % No % P
Before
No 9 75.0 11 61.11
Trivial 0 0.0 3 16.67 2.233
Mild 3 25.0 4 22.22 0.327
Immediate follow up
No 3 25.0 0 0.0 5.54
Trivial 2 16.67 2 11.11 0.06
Mild 7 58.33 16 88.89
3 months after
No 3 25.0 0 0.0 5.54
Trivial 2 16.67 2 11.11 0.06
Mild 7 58.33 16 88.89
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creased with the number and the extent of commissural open-
ing. Our results conﬁrmed the impression that older patientshad less chance to open more commissures. In agreement with
the present study, David et al.,15 studied the impact of degree
of commissural opening after percutaneous mitral commissur-
otomy on long-term outcome, where patients were divided into
3 groups: both commissures only partially opened or not split,
one commissure completely split and both commissures com-
pletely split. Patients in the ﬁrst group were older.
In concordance to our results, David et al.,15 reported a sig-
niﬁcant difference as regards the post-procedure mean trans-
mitral gradient and MVA in patients with bilateral
commissural opening. Thus, mean transmitral gradient de-
creased and MVA increased parallel to the degree of commis-
sural opening. D Fatkin et al.16 also reported similar data.
They studied 30 consecutive patients, on the basis of the
two-dimensional echocardiographic commissural morphology:
the extent of fusion, ﬁbrosis or calciﬁcation of each commis-
sure. Splitting of one or both commissures occurred in 24 pa-
tients (80%) and was associated with a signiﬁcantly greater
mean increase in valve area (85%) than if neither commissure
Figure 2 Example of a case before and after PBMV.
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votomy (deﬁned as valve area > 1.5 cm2 and increase in valve
area > 25%) was achieved in 96% of those in whom one or
both commissures split, but in none of the patients in whom
neither commissure split. Consequently, the splitting of one
or both commissures was associated with a good outcome in
23 (89%) of 26 patients, on the other hand when both commis-
sures remained closed the outcome was not good in any
patient.
As regards post-procedural mitral regurgitation, the current
study revealed that opening of 2 commissures in group II re-
sulted in more patients developing new mild mitral regurgita-
tion than opening of one commissure in group I with no
signiﬁcant impact on outcome. In agreement with our results,
Duk-Hyun Kang et al.17 studied 302 consecutive patients in a
prospective, randomized trial comparing two procedures, pa-
tients who underwent percutaneous mitral valvuloplasty
(PMV) using Inoue or double-balloon technique, found that
both the Inoue and double-balloon techniques obtained a sim-
ilar incidence of commissural mitral regurgitation. The annual
echocardiographic follow-up data suggested that the natural
course of most commissural mitral regurgitation was benign
during follow-up and that the rate of decrease in MVA after
PMV was signiﬁcantly slower in patients with commissural mi-
tral regurgitation compared with those without commissural
regurgitation. Previous studies also reported that the mecha-
nisms of development of MR after PMV were different for
mild and severe MR. Mild MR was produced by complete
commissurotomy, but severe MR was produced by leaﬂet tears
or chordal rupture.18,19 The mechanism by which commissural
regurgitation maintains initial gain in MVA is unclear. Thedecrease in MVA after PMV may be related to the fusion of
split commissure and recoil of the stretch component. Com-
plete commissurotomy and commissural regurgitation might
prevent immediate recoil and late fusion by preventing apposi-
tion of split commissures.
While PBMV is a safe and effective procedure for the treat-
ment of rheumatic MS, development of atrial ﬁbrillation (AF),
redo PBMV, or the need of surgical intervention is not uncom-
mon during long term follow up. In our study no one had early
onset (3 months) of AF, redo or surgery. Atrial ﬁbrillation is a
common late complication of mitral stenosis.20 It is already
reported that AF is an important predictor for unfavorable
clinical outcome (death, reintervention or mitral valve replace-
ment) and restenosis after PBMV. Chronic AF was the only
factor with predictive value for these events before interven-
tion. The duration of chronic AF was also important for its
predictive value if chronic AF at the time of PBMV had been
present for more than one year, the risk of an event or resteno-
sis during follow-up increased seven fold.21 Independent pre-
dictors for the need to undergo surgery after PMV include
the presence of signiﬁcant MR after PBMV, the echo score
before PBMV, the residual mitral gradient after PBMV, and
the NYHA score at ﬁrst follow-up. This partially agrees with
the results of David et al.15 which showed the impact of com-
missural splitting on late functional results. Mean follow-up
duration was 55 ± 28 months. During follow-up, 0.02% car-
diovascular deaths were observed, and 11% underwent repeat
PMC or mitral valve surgery. The difference of result of follow
up between our study and David et al.15 may be explained by
short period of follow up and smaller number of patients in
our study.
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Commissural splitting is the dominant mechanism by which
mitral valve area is increased in PBMV, and it can be predicted
by echocardiographic assessment of commissural morphology.
Mitral valve commissural morphology should be evaluated
properly when selecting patients before percutaneous balloon
mitral valvuloplasty. The present study demonstrates that
commissural opening degree and mitral valve area are closely
related. The degree of commissural opening provides impor-
tant prognostic information, and complete commissural open-
ing is associated with better results. Degree of commissural
opening should be systematically evaluated during and after
percutaneous balloon mitral valvuloplasty and can be consid-
ered as a complementary measure of the procedural success.
7. Study limitations
These results are to be interpreted in consideration of the small
number of patients and short duration of follow up.
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